Exhibit 10.1
EXECUTION COPY
INVESTMENT
AGREEMENT
dated as of July 27,
2009
between
W EBSTER F INANCIAL C ORPORATION
and
W ARBURG P INCUS P RIVATE E QUITY X, L.P.
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
Page
|
|
ARTICLE I
|
|
|
Purchase; Closings
|
|
|
|
|
1.1
|
|
Purchase
|
|
2
|
|
1.2
|
|
Closings
|
|
2
|
|
1.3
|
|
Second Closing
Adjustments
|
|
6
|
|
|
ARTICLE II
|
|
|
Representations and
Warranties
|
|
|
|
|
2.1
|
|
Disclosure
|
|
8
|
|
2.2
|
|
Representations
and Warranties of the Company
|
|
9
|
|
2.3
|
|
Representations
and Warranties of the Investor
|
|
26
|
|
|
ARTICLE III
|
|
|
Covenants
|
|
|
|
|
3.1
|
|
Filings; Other
Actions
|
|
28
|
|
3.2
|
|
Expenses
|
|
31
|
|
3.3
|
|
Access,
Information and Confidentiality
|
|
31
|
|
|
ARTICLE IV
|
|
|
Additional Agreements
|
|
|
|
|
4.1
|
|
Agreement
|
|
32
|
|
4.2
|
|
No Rights
Agreement
|
|
35
|
|
4.3
|
|
Gross-Up
Rights
|
|
35
|
|
4.4
|
|
Governance
Matters
|
|
37
|
|
4.5
|
|
Legend
|
|
40
|
|
4.6
|
|
Reservation for
Issuance; Exchange Listing
|
|
40
|
|
4.7
|
|
Certain
Transactions
|
|
40
|
|
4.8
|
|
Extension
Periods
|
|
41
|
|
4.9
|
|
Indemnity
|
|
41
|
|
4.10
|
|
Intentionally
Omitted
|
|
43
|
|
4.11
|
|
Registration
Rights
|
|
43
|
|
4.12
|
|
Transfer
Restrictions
|
|
55
|
|
4.13
|
|
Certificates of
Designations
|
|
55
|
-i-
|
|
|
|
|
|
4.14
|
|
Voting
|
|
55
|
|
4.15
|
|
Additional
Regulatory Matters
|
|
55
|
|
|
ARTICLE V
|
|
|
Termination
|
|
|
|
|
5.1
|
|
Termination
|
|
57
|
|
5.2
|
|
Effects of
Termination
|
|
58
|
|
|
ARTICLE VI
|
|
|
Miscellaneous
|
|
|
|
|
6.1
|
|
Survival
|
|
58
|
|
6.2
|
|
Amendment
|
|
58
|
|
6.3
|
|
Waivers
|
|
58
|
|
6.4
|
|
Counterparts
and Facsimile
|
|
58
|
|
6.5
|
|
Governing
Law
|
|
59
|
|
6.6
|
|
WAIVER OF JURY
TRIAL
|
|
59
|
|
6.7
|
|
Notices
|
|
59
|
|
6.8
|
|
Entire
Agreement, Etc.
|
|
60
|
|
6.9
|
|
Other
Definitions
|
|
61
|
|
6.10
|
|
Captions
|
|
62
|
|
6.11
|
|
Severability
|
|
62
|
|
6.12
|
|
No Third Party
Beneficiaries
|
|
62
|
|
6.13
|
|
Time of
Essence
|
|
62
|
|
6.14
|
|
Public
Announcements
|
|
62
|
|
6.15
|
|
Specific
Performance
|
|
62
|
-ii-
LIST OF EXHIBITS
|
|
|
|
Exhibit A:
|
|
Form of
A-Warrant, Series 1 Certificate
|
|
|
|
Exhibit
B:
|
|
Form of
B-Warrant, Series 1 Certificate
|
|
|
|
Exhibit
C:
|
|
Form of Series
C Certificate
|
|
|
|
Exhibit
D:
|
|
Form of
A-Warrant, Series 2 Certificate
|
|
|
|
Exhibit
E:
|
|
Form of
B-Warrant, Series 2 Certificate
|
|
|
|
Exhibit
F:
|
|
Form of Series
D Certificate
|
|
|
|
Exhibit
G:
|
|
Form of Opinion
of Counsel (Second Closing)
|
-iii-
INDEX OF DEFINED
TERMS
|
|
|
|
|
|
Location of
Definition
|
|
A-Warrant, Series 1
|
|
Recitals
|
|
A-Warrant, Series 2
|
|
Recitals
|
|
A-Warrant, Series 1 Certificate
|
|
Recitals
|
|
A-Warrant, Series 2 Certificate
|
|
Recitals
|
|
Affiliate
|
|
6.9(2)
|
|
Agreement
|
|
Preamble
|
|
B-Warrant, Series 1
|
|
Recitals
|
|
B-Warrant, Series 2
|
|
Recitals
|
|
B-Warrant, Series 1 Certificate
|
|
Recitals
|
|
B-Warrant, Series 2 Certificate
|
|
Recitals
|
|
Beneficially Own/Beneficial Owner/Beneficial
Ownership
|
|
6.9(8)
|
|
Benefit Plan
|
|
2.2(p)(1)
|
|
BHC Act
|
|
1.2(c)(2)(v)
|
|
Board of Directors
|
|
2.2(d)(1)
|
|
Board Representative
|
|
4.4(f)
|
|
Business Combination
|
|
4.1
|
|
business day
|
|
6.9(6)
|
|
Capitalization Date
|
|
2.2(c)
|
|
CERCLA
|
|
2.2(u)
|
|
Certificate of Incorporation
|
|
Recitals
|
|
Change in Control
|
|
4.1
|
|
CIBC Act
|
|
1.2(c)(2)(vi)
|
|
Closings
|
|
1.2(b)(1)
|
|
Code
|
|
2.2(p)(2)
|
|
Common Stock/Common Shares
|
|
Recitals
|
|
Company
|
|
Preamble
|
|
Company 10-K
|
|
2.2(f)
|
|
Company Financial Statements
|
|
2.2(f)
|
|
Company Preferred Stock
|
|
2.2(c)
|
|
Company Reports
|
|
2.2(g)(1)
|
|
Company Significant Agreement
|
|
2.2(k)
|
|
Company Subsidiary/Company
Subsidiaries
|
|
2.2(b)
|
|
control/controlled by/under common control
with
|
|
6.9(2)
|
|
Delaware Secretary
|
|
Recitals
|
|
Disclosure Schedule
|
|
2.1(a)
|
|
ERISA
|
|
2.2(p)(1)
|
|
ERISA Affiliate
|
|
2.2(p)(2)
|
|
Exchange Act
|
|
2.2(g)(1)
|
|
Extension Period
|
|
4.8
|
|
FDIC
|
|
2.2(b)
|
|
Federal Reserve
|
|
1.2(c)(2)(v)
|
-iv-
|
|
|
|
|
|
Location of
Definition
|
|
First Closing
|
|
1.2(a)(1)
|
|
First Closing Date
|
|
1.2(a)(1)
|
|
GAAP
|
|
2.1(b)
|
|
Governance Committee
|
|
4.4(a)
|
|
Governmental Entity
|
|
1.2(c)(1)(i)
|
|
herein/hereof/hereunder
|
|
6.9(5)
|
|
Holder
|
|
4.11(k)(1)
|
|
Holders’ Counsel
|
|
4.11(k)(2)
|
|
HSR Act
|
|
2.2(d)(3)
|
|
Including/includes/included/include
|
|
6.9(4)
|
|
Incumbent Directors
|
|
4.1
|
|
Indemnified Party
|
|
4.9(c)
|
|
Indemnifying Party
|
|
4.9(c)
|
|
Indemnitee
|
|
4.11(g)(1)
|
|
Information
|
|
3.3(b)
|
|
Initial Purchase Price
|
|
1.2(a)(2)
|
|
Intellectual Property
|
|
2.2(w)
|
|
Investor
|
|
Preamble
|
|
IRS
|
|
2.2(i)
|
|
knowledge of the Company/Company’s
knowledge
|
|
6.9(9)
|
|
Liens
|
|
2.2(b)
|
|
Losses
|
|
4.9(a)
|
|
Material Adverse Effect
|
|
2.1(b)
|
|
Meeting End Date
|
|
3.1(b)
|
|
New Security
|
|
4.3(a)
|
|
Non-Qualifying Transaction
|
|
4.1
|
|
Observer
|
|
4.4(d)
|
|
or
|
|
6.9(3)
|
|
Parent Corporation
|
|
4.1
|
|
Pending Underwritten Offering
|
|
4.11(l)
|
|
Permitted Liens
|
|
2.2(h)
|
|
Person
|
|
6.9(7)
|
|
Piggyback Registration
|
|
4.11(a)(4)
|
|
Preferred Stock/Preferred Shares
|
|
Recitals
|
|
Preferred Stock Certificates of
Designations
|
|
Recitals
|
|
Previously Disclosed
|
|
2.1(c)
|
|
Purchase Price
|
|
1.2(b)(2)
|
|
Qualifying Ownership Interest
|
|
4.4(a)
|
|
Rating Agencies
|
|
2.2(cc)
|
|
register/registered/registration
|
|
4.11(k)(3)
|
|
Registrable Securities
|
|
4.11(k)(4)
|
|
Registration Deadline
|
|
4.11(a)(1)
|
|
Registration Expenses
|
|
4.11(k)(5)
|
-v-
|
|
|
|
|
|
Location of
Definition
|
|
Regulatory Agreement
|
|
2.2(y)
|
|
Rule 144
|
|
4.11(k)(6)
|
|
Rule 144A
|
|
4.11(k)(6)
|
|
Rule 158
|
|
4.11(k)(6)
|
|
Rule 159A
|
|
4.11(k)(6)
|
|
Rule 405
|
|
4.11(k)(6)
|
|
Rule 415
|
|
4.11(k)(6)
|
|
Scheduled Black-out Period
|
|
4.11(k)(7)
|
|
SEC
|
|
2.2(f)
|
|
Second Closing Warrants
|
|
1.3(a)
|
|
Section 16(b) Period
|
|
4.8
|
|
Second Closing
|
|
1.2(b)(1)
|
|
Second Closing Date
|
|
1.2(b)(1)
|
|
Second Purchase Price
|
|
1.2(b)(2)
|
|
Second Closing Securities
|
|
1.2(b)(2)
|
|
Securities
|
|
Recitals
|
|
Securities Act
|
|
2.2(g)(1)
|
|
Selling Expenses
|
|
4.11(k)(8)
|
|
Series A Stock
|
|
2.2(c)
|
|
Series B Stock
|
|
2.2(c)
|
|
Series C Certificate
|
|
Recitals
|
|
Series C Shares
|
|
Recitals
|
|
Series C Stock
|
|
Recitals
|
|
Series D Certificate
|
|
Recitals
|
|
Series D Shares
|
|
Recitals
|
|
Series D Stock
|
|
Recitals
|
|
Shelf Registration Statement
|
|
4.11(a)(2)
|
|
Special Registration
|
|
4.11(a)(4)
|
|
Stockholder Proposals
|
|
3.1(b)
|
|
subsidiary
|
|
6.9(1)
|
|
Surviving Corporation
|
|
4.1
|
|
Tax/Taxes
|
|
2.2(i)
|
|
Threshold Amount
|
|
4.9(e)
|
|
Transaction Documents
|
|
Recitals
|
|
Transfer
|
|
4.12
|
|
Unlawful Gains
|
|
2.2(n)(5)
|
|
Voting Debt
|
|
2.2(c)
|
|
Voting Securities
|
|
4.1
|
|
Warrants
|
|
Recitals
|
-vi-
INVESTMENT AGREEMENT
, dated as of July 27, 2009
(this “ Agreement ”), between Webster Financial
Corporation, a Delaware corporation (the “ Company
”), and Warburg Pincus Private Equity X, L.P., a Delaware
limited partnership (the “ Investor
”).
RECITALS:
A. The Investment . The
Company intends to sell to the Investor, and the Investor intends
to purchase from the Company, as an investment in the Company, the
securities as described herein.
The securities to be purchased at
the first closing are 4,024,600 shares of Common Stock, par value
$0.01 per share, of the Company (the “ Common Stock
” or “ Common Shares ”). In connection
with the purchase and sale of the Common Stock at the first
closing, the Company intends to issue the Investor (i) a
warrant (an “ A-Warrant, Series 1 ”) to purchase
1,843,100 shares of Common Stock, having the terms set forth in
Exhibit A and (ii) a warrant (a “ B-Warrant, Series
1 ”) to purchase 11,753 shares of Series C Stock (as
defined below), having the terms set forth in Exhibit B.
The securities to be purchased at
the second closing, subject to adjustment as of the date of the
second closing in accordance with the terms hereof, are
(i) 3,018,400 shares of Common Stock and (ii) 44,570
shares of Series C perpetual participating preferred stock, par
value $0.01 per share, of the Company, having the terms set forth
in Exhibit C (the “ Series C Stock ” or
“ Series C Shares ”). In connection with
the purchase and sale of the Common Stock and the Series C
Stock at the second closing, the Company intends to issue the
Investor (i) a warrant (the “ A-Warrant, Series 2
”) to purchase 67,819 shares of Series C Stock, having the
terms set forth in Exhibit D and (ii) a warrant (the “
B-Warrant, Series 2 ” and, together with the
A-Warrant, Series 1, the A-Warrant, Series 2 and the B-Warrant,
Series 1, the “ Warrants ”) to purchase 43,247
shares of Series C Stock, having the terms set forth in
Exhibit E. In certain circumstances as set forth therein, the
Warrants may settle in shares of Series D perpetual
participating preferred stock, par value $0.01 per share of the
Company (the “ Series D Stock ” or “
Series D Shares ” and, together with the
Series C Stock, the “ Preferred Stock ” or
“ Preferred Shares ”).
B. The Securities . The term
“ Securities ” refers collectively to
(1) the shares of Common Stock and Series C Stock
purchased under this Agreement, (2) the Warrants issued under
this Agreement, and (3) any securities (including shares of
Common Stock and Preferred Stock) into which any of the foregoing
are converted, exchanged or exercised in accordance with the terms
thereof and of this Agreement. When issued, the Series C Stock
and Series D Stock will have the designations, relative
rights, preferences and limitations set forth in a certificate of
designations, substantially in the forms attached as Exhibit C (the
“ Series C Certificate ”) and
Exhibit F (the “ Series D Certificate
” and , together with the Series C Certificate, the
“ Preferred Stock Certificate of Designations
”), respectively, in each case, made a part of the
Company’s Second Restated Certificate of Incorporation, as
amended on June 10, 1998 (the “ Certificate
of
Incorporation ”), by the filing of each Preferred Stock
Certificate of Designations with the Secretary of State of the
State of Delaware (the “ Delaware Secretary ”).
When issued, the A-Warrant, Series 1, B-Warrant, Series 1,
A-Warrant, Series 2 and B-Warrant, Series 2 will be evidenced by
certificates substantially in the forms attached as Exhibit A
(the “ A-Warrant, Series 1 Certificate ”),
Exhibit B (the “ B-Warrant, Series 1 Certificate
”), Exhibit D (the “ A-Warrant, Series 2
Certificate ”) and Exhibit E (the “
B-Warrant, Series 2 Certificate ”) ,
respectively.
C. Transaction Documents .
The term “ Transaction Documents ” refers
collectively to this Agreement, the A-Warrant, Series 1
Certificate, the B-Warrant, Series 1 Certificate, the A-Warrant,
Series 2 Certificate, the B-Warrant, Series 2 Certificate and the
Preferred Stock Certificate of Designations.
NOW , THEREFORE , in consideration of the
premises, and of the representations, warranties, covenants and
agreements set forth herein, the parties agree as
follows:
ARTICLE I
Purchase; Closings
1.1 Purchase . On the terms
and subject to the conditions set forth herein, the Investor will
(i) purchase from the Company, and the Company will sell to
the Investor, a number of shares of Common Stock and Series C
Stock as set forth herein and (ii) receive from the Company,
and the Company will deliver to the Investor, the
Warrants.
1.2 Closings . The
transactions contemplated hereby will occur over two
closings.
(a) First Closing .
(1) The first closing (the “ First Closing
”) shall take place immediately following the execution and
delivery of this Agreement, at the offices of Sullivan &
Cromwell LLP located at 125 Broad Street, New York, New York 10004
or such other location as agreed by the parties. The date of the
First Closing is referred to as the “ First Closing
Date .”
(2) At the First Closing, the
Company will deliver to the Investor (i) one or more
certificates representing 4,024,600 shares of Common Stock,
(ii) one or more certificates representing the A-Warrant,
Series 1 exercisable to purchase 1,843,100 shares of Common
Stock and (iii) one or more certificates representing the
B-Warrant, Series 1 exercisable to purchase 11,753 shares of
Series C Stock against (2) payment by the Investor by
wire transfer of immediately available United States funds to a
bank account designated by the Company for an aggregate purchase
price of $40,246,000 (the “ Initial Purchase Price
”).
-2-
(b) Second Closing .
(1) Subject to the satisfaction or waiver of the conditions to
the second closing (the “ Second Closing ” and,
together with the First Closing, the “ Closings
”) set forth in Section 1.2(c), the Second Closing shall
take place at a time and date as shall be agreed upon by the
parties hereto, but no later than the third business day after the
date of satisfaction or waiver of the last of the conditions
specified in Section 1.2(c), at the offices of
Sullivan & Cromwell LLP located at 125 Broad Street, New
York, New York 10004 or such other date or location as agreed
by the parties. The date of the Second Closing is referred to as
the “ Second Closing Date .”
(2) Subject to the satisfaction or
waiver on the Second Closing Date of the conditions to the Second
Closing in Section 1.2(c), at the Second Closing, the Company
will deliver to the Investor (i) certificates representing
3,018,400 shares of Common Stock, (ii) 44,570 shares of
Series C Stock; (iii) one or more certificates
representing the A-Warrant, Series 2 exercisable to purchase 67,819
shares of Series C Stock and (iv) one or more certificates
representing the B-Warrant, Series 2 exercisable to purchase 43,247
shares of Series C Stock (subject to adjustment in accordance
with the terms hereof, such securities under (i), (ii),
(iii) and (iv), collectively, the “ Second Closing
Securities ”) against (2) payment by the Investor by
wire transfer of immediately available United States funds to a
bank account designated by the Company for an aggregate purchase
price of $74,754,000 (the “ Second Purchase Price
” and, together with the Initial Purchase Price, the “
Purchase Price ”).
(c) Closing Conditions .
(1) The respective obligation of each of the Investor and the
Company to consummate the Second Closing is subject to the
fulfillment or written waiver by the Investor and the Company prior
to the Second Closing of the following conditions:
(i) no provision of any applicable
law or regulation and no judgment, injunction, order or decree of
any Governmental Entity (as defined below) of competent
jurisdiction shall prohibit the Second Closing or shall prohibit or
restrict the Investor or its Affiliates from owning, voting, or,
subject to receipt of approval of the Stockholder Proposals,
converting or exercising any Securities in accordance with the
terms thereof and no lawsuit has been commenced by any governmental
or regulatory authorities, agencies, courts, commissions or other
entities, whether federal, state, local or foreign, or applicable
self-regulatory organizations (each, a “ Governmental
Entity ”) of competent jurisdiction seeking to effect any
of the foregoing; and
(ii) the shares of Common Stock to
be issued in the Second Closing pursuant to this Agreement and the
shares of Common Stock into which all of the Preferred Shares are
convertible and for which the Warrants may be exercised shall have
been authorized for listing on the New York Stock Exchange or such
other market on which the Common Stock is then listed or quoted,
subject to official notice of issuance.
-3-
(2) The obligation of the Investor
to consummate the Second Closing is also subject to the fulfillment
or written waiver prior to the Second Closing of each of the
following conditions:
(i) the representations and
warranties of the Company set forth in (A) Sections 2.2(a),
(d)(1), (d)(2)(A), (d)(3), (q), (x), (aa), (bb) and (l) of
this Agreement shall be true and correct in all respects,
(B) Section 2.2(c) shall be true and correct except to a
de minimis extent (relative to such Section 2.2(c) taken as a
whole), and (C) Section 2.2(b) shall be true and correct
in all material respects, in each case of (A), (B) and (C), on
and as of the date of this Agreement and on and as of the Second
Closing Date as though made on and as of the Second Closing Date
(except to the extent such representations and warranties are made
as of a specified date, in which case such representations and
warranties shall be true and correct in such respect set forth
above as of such date);
(ii) the Company shall have
performed in all material respects all obligations required to be
performed by it at or prior to the Second Closing under this
Agreement;
(iii) the Investor shall have
received a certificate, dated the Second Closing Date, signed on
behalf of the Company by a senior executive officer certifying to
the effect that the conditions set forth in
Sections 1.2(c)(2)(i) and (ii) have been
satisfied;
(iv) the Investor shall have
received from outside counsel to the Company, a written opinion
dated the Second Closing Date in the form attached hereto as
Exhibit G;
(v) the Investor shall have received
written confirmation, satisfactory to it in its reasonable good
faith judgment, from the Board of Governors of the Federal Reserve
System (the “ Federal Reserve ”) to the effect
that neither the Investor nor any of its Affiliates (which for
purposes of this clause (v) and clause (vi) below shall
include all “affiliates” as defined in the Bank Holding
Company Act of 1956, as amended, or any successor statute (the
“ BHC Act ”) or Regulation Y of the Federal
Reserve) shall be deemed to “control” the Company or
any Company Subsidiary for purposes of the BHC Act by reason of the
consummation of the transactions contemplated by this Agreement and
the other Transaction Documents; provided , however ,
that such written confirmation shall be deemed to be satisfactory
to the Investor if such written confirmation (including any
conditions imposed by the Federal Reserve such as any required
passivity commitments) is reasonably consistent with the
regulations, supervisory guidance, policy statements and practices
of the Federal Reserve, as of the date of this Agreement, in
comparable transactions, and provided , further ,
that the Investor shall not be entitled to rely on this condition
to avoid effecting the Second Closing if the Investor shall not
have complied in all material respects with its covenants and
agreements herein.
-4-
(vi) To the extent required by
applicable law the Investor shall have received written approval of
its notice filed with the Federal Reserve pursuant to the Change in
Bank Control Act of 1978, as amended (the “ CIBC Act
”); and
(vii) in the case of clauses
(v) and (vi) above, such receipt of written confirmation
and approval, as applicable, shall have been provided without the
Investor or any of its Affiliates being subject to any restrictions
or other obligations described in Section 4.15(b).
(3) The obligation of the Company to
consummate the Second Closing is also subject to the fulfillment or
written waiver prior to the Second Closing of the following
conditions:
(i) the representations and
warranties of the Investor set forth in Sections 2.3(a), (b)(1),
(b)(2)(A), (b)(3), (c), (d) and (g) of this Agreement
shall be true and correct in all respects on and as of the date of
this Agreement and on and as of the Second Closing Date as though
made on and as of the Second Closing Date (except to the extent
such representations and warranties are made as of a specified
date, in which case such representations and warranties shall be
true and correct as of such date);
(ii) the Investor shall have
received written confirmation, satisfactory to the Company in its
reasonable good faith judgment solely with respect to any adverse
effect on the Company resulting therefrom, if any, from the Federal
Reserve to the effect that neither the Investor nor any of its
Affiliates (which for purposes of this clause (vi) and clause
(vii) below shall include all “affiliates” as
defined in BHC Act or Regulation Y of the Federal Reserve)
shall be deemed to “control” the Company or any Company
Subsidiary for purposes of the BHC Act by reason of the
consummation of the transactions contemplated by this Agreement and
the other Transaction Documents; provided , however ,
that such written confirmation shall be deemed to be satisfactory
to the Company solely with respect to any adverse effect on the
Company resulting therefrom, if any, if such written confirmation
(including any conditions imposed by the Federal Reserve such as
any required passivity commitments) is reasonably consistent with
the regulations, supervisory guidance, policy statements and
practices of the Federal Reserve, as of the date of this Agreement,
in comparable transactions, and provided , further ,
that the Company shall not be entitled to rely on this condition to
avoid effecting the Second Closing if the Company shall not have
complied in all material respects with its covenants and agreements
herein;
(iii) to the extent required by
applicable law the Investor shall have received written approval of
its notice filed with the Federal Reserve pursuant to the CIBC
Act;
-5-
(iv) the Investor has performed in
all material respects all obligations required to be performed by
it at or prior to the Second Closing under Section 3.1;
and
(v) the Company shall have received
a certificate signed on behalf of the Investor by a senior
executive officer certifying to the effect that the conditions set
forth in Sections 1.2(c)(3)(i) and (iv) have been
satisfied.
(4) Notwithstanding anything to the
contrary in this Agreement, upon a Change in Control (as defined
below), (i) the Company’s closing conditions to the
Second Closing set forth in Section 1.2(c)(1)(ii) and the
requirement in Section 1.2(c)(3)(ii) that the confirmation
referred to therein be satisfactory to the Company in its
reasonable good faith judgment, in each case, shall be deemed fully
and irrevocably waived and (ii) the Company’s closing
condition to the Second Closing set forth in
Section 1.2(c)(3)(i) shall be deemed to be met at the Second
Closing provided that there is no breach of the Investor’s
representations and warranties applicable to such closing condition
that affects the performance of the terms of this Agreement in any
material respect or the regulatory status of the
Company.
1.3 Second Closing
Adjustments .
(a) In the event that, at or prior
to the Second Closing, there occurs any transaction that would
result in any adjustment or give rise to any right under
Section 13 of the A-Warrant, Series 2 or Section 13 of
the B-Warrant, Series 2 (together with the A-Warrant, Series 2, the
“ Second Closing Warrants ”) if the applicable
transaction were to occur after the Second Closing, then at the
Investor’s option, which may be exercised in the
Investor’s sole discretion, the forms of the Second Closing
Warrants shall be amended, automatically and without action on the
part of the parties to this Agreement, to reflect any adjustment to
or right in respect of (x) the Exercise Price (as defined in
the Second Closing Warrants) and (y) the amount and nature of
shares of stock or other securities or property (including cash)
that a warrantholder would receive upon the exercise of the Second
Closing Warrants, in each case, that would be effected or created
in accordance with Section 13 of the A-Warrant, Series 2 or
Section 13 of the B-Warrant, Series 2 as if the Second Closing
Warrants had been issued to the Investor on the date of this
Agreement and were in effect at the time of the applicable
transaction. In connection with such amendment, all references to
the Second Closing Warrants in this Agreement shall be conformed,
automatically and without action on the part of the parties to this
Agreement; provided , however , that notwithstanding
anything in this Agreement to the contrary, in no event shall the
Purchase Price or any component thereof be changed by the
foregoing).
(b) In the event that, at or prior
to the Second Closing, (i) the number of shares of Common
Stock or securities convertible or exchangeable into or exercisable
for shares of Common Stock issued and outstanding is changed as a
result of any
-6-
reclassification, stock split (including reverse
split), stock dividend or distribution (including any dividend or
distribution of securities convertible or exchangeable into or
exercisable for shares of Common Stock), merger, tender or exchange
offer or other similar transaction, or (ii) the Company fixes
a record date that is at or prior to the Second Closing Date for
the payment of any non-stock dividend or distribution on the Common
Stock other than any Ordinary Cash Dividends (as defined in the
Second Closing Warrants), then at the Investor’s option,
which may be exercised in the Investor’s sole discretion, the
number of shares of Common Stock to be issued to the Investor at
the Second Closing under this Agreement shall be equitably adjusted
and/or the shares of Common Stock to be issued to the Investor at
the Second Closing under this Agreement shall be equitably
substituted with shares of other stock or securities or property
(including cash), in each case, to provide the Investor with
substantially the same economic benefit from this Agreement as the
Investor had prior to the applicable transaction. Notwithstanding
anything in this Agreement to the contrary, in no event shall the
Purchase Price or any component thereof be changed by the
foregoing.
(c) In the event that, at or prior
to the Second Closing, there occurs any transaction that would
result in any adjustment or give rise to any right under
Section 10 or Section 11 of the Series C Certificate or
Section 10 or Section 11 of the Series D Certificate with
respect to Series C Stock or the Series D Stock, as the case may
be, if the applicable Preferred Stock Certificate of Designations
had been filed with the State of Delaware and were in full force
and effect, then at the Investor’s option, which may be
exercised in the Investor’s sole discretion, the number of
shares of Series C Stock (or, if applicable, Series D Stock) to be
issued to the Investor at the Second Closing under this Agreement
shall be equitably adjusted and/or the shares of Series C Stock
(or, if applicable, Series D Stock) to be issued to the Investor at
the Second Closing under this Agreement shall be equitably
substituted with shares of other stock or securities or property
(including cash), in each case, to provide the Investor with
substantially the same economic benefit as the Investor would have
had if the applicable Preferred Stock Certificate of Designations
had been filed with the State of Delaware and were in full force
and effect and the Investor had held Series C Stock (or, if
applicable, Series D Stock) at the time of the applicable
transaction. Notwithstanding anything in this Agreement to the
contrary, in no event shall the Purchase Price or any component
thereof be changed by the foregoing.
(d) Notwithstanding anything in this
Agreement to the contrary, the Company shall not directly or
indirectly effect or cause to be effected any transaction with a
third party that would reasonably be expected to result in a Change
in Control unless such third party shall have provided prior
assurance in writing to the Investor (in a form that is reasonably
satisfactory to the Investor) that the terms of this Agreement,
including this Section 1.3, shall be fully performed
(i) by the Company or (ii) by such third party if it is
the successor of the Company or if the Company is its direct or
indirect subsidiary. For the avoidance of doubt, it is understood
and agreed that, in the event that a Change in Control occurs prior
to the Second Closing, the Investor shall maintain the right under
this Agreement to acquire, pursuant to the terms and conditions of
this
-7-
Agreement, the Second Closing Securities (or
such shares of stock or other securities or property (including
cash) into which the Second Closing Securities may have become
exchangeable as a result of such Change in Control), as if the
Second Closing had occurred immediately prior to such Change in
Control.
ARTICLE II
Representations and
Warranties
2.1 Disclosure . (a) On or
prior to the date of this Agreement, each of the Company and the
Investor delivered to the other a schedule (“ Disclosure
Schedule ”) setting forth, among other things, items the
disclosure of which is necessary or appropriate either in response
to an express disclosure requirement contained in a provision
hereof or as an exception to one or more representations or
warranties contained in Section 2.2 with respect to the
Company, or in Section 2.3 with respect to the Investor, or to
one or more of its covenants contained in Article III; provided,
however, that notwithstanding anything in this Agreement to the
contrary, the mere inclusion of an item in such schedule shall not
be deemed an admission that such item represents a material
exception or material fact, event or circumstance or that such item
has had or would reasonably be expected to have a Material Adverse
Effect on the Company or the Investor, as applicable.
(b) “ Material Adverse
Effect ” means, with respect to the Investor, only
clause (2) that follows, or, with respect to the Company, both
clauses (1) and (2) that follow, any circumstance, event,
change, development or effect that, individually or in the
aggregate (1) is material and adverse to the financial
position, results of operations, business or condition (financial
or otherwise) of the Company and its Subsidiaries taken as a whole,
or (2) would materially impair the ability of either the
Investor or the Company, respectively, to perform its obligations
under this Agreement or otherwise materially threaten or materially
impede the consummation of the transactions contemplated by this
Agreement; provided , however , that Material Adverse
Effect, under clause (1), shall not be deemed to include the
impact of (A) changes, after the date of this Agreement, in
the U.S. generally accepted accounting principles (“
GAAP ”) (B) changes, after the date hereof, in
applicable laws, rules and regulations or interpretations thereof
by Governmental Entities, (C) actions or omissions of the
Company expressly required by the terms of this Agreement or taken
with the prior written consent of the Investor, (D) general
changes in the economy or the industries in which the Company and
its Subsidiaries operate, (E) changes in the market price or
trading volumes of the Common Stock or the Company’s other
securities (but not the underlying causes of such changes),
(F) the failure of the Company to meet any internal or public
projections, forecasts, estimates or guidance (but not the
underlying causes of such failure), and (G) the public
disclosure of this Agreement or the transactions contemplated
hereby, in each case to the extent that such circumstances, events,
changes, developments or effects described in the foregoing
clauses (A), (B) and (D) do not have a
disproportionate effect on the Company and its Subsidiaries, taken
as a whole (relative to other industry participants in the
industries in which the Company and its Subsidiaries
compete.)
-8-
(c) “ Previously
Disclosed ” with regard to (1) any party means
information set forth on its Disclosure Schedule corresponding
to the provision of this Agreement to which such information
relates; provided that information which, on its face,
reasonably should indicate to the reader that it relates to another
provision of this Agreement, shall also be deemed to be Previously
Disclosed with respect to such other provision and (2) the
Company, includes information publicly disclosed by the Company in
the Company Reports filed by it with or furnished to the SEC and
publicly available prior to the date of this Agreement (excluding
any risk factor disclosures contained in such documents under the
heading “Risk Factors” and any disclosure of risks
included in any “forward-looking statements” disclaimer
or other statements that are similarly non-specific and are
predictive or forward-looking in nature).
2.2 Representations and
Warranties of the Company . Except as Previously Disclosed, the
Company represents and warrants as of the date of this Agreement
and as of the Second Closing Date (except to the extent made only
as of a specified date, in which case as of such date) to the
Investor that:
(a) Organization and
Authority . The Company is a corporation duly organized,
validly existing and in good standing under the laws of the State
of Delaware, is duly qualified to do business and is in good
standing in all jurisdictions where its ownership or leasing of
property or the conduct of its business requires it to be so
qualified and failure to be so qualified would have a Material
Adverse Effect on the Company and has corporate power and authority
to own its properties and assets and to carry on its business as it
is now being conducted. The Company is duly registered as a bank
holding company under the BHC Act, has duly elected to be treated
as a “financial holding company” thereunder and remains
a “financial holding company” in good standing and
allowed to exercise all powers of a “financial holding
company” thereunder. The Company has furnished or made
available to the Investor true, correct and complete copies of the
Company’s Certificate of Incorporation and bylaws as amended
through the date of this Agreement.
(b) Company’s
Subsidiaries . The Company has Previously Disclosed a true,
complete and correct list of all of its subsidiaries as of the date
of this Agreement (individually, a “ Company
Subsidiary ” and, collectively, the “ Company
Subsidiaries ”), all shares of the outstanding capital
stock of each of which are owned directly or indirectly by the
Company. No equity security of any Company Subsidiary is or may be
required to be issued by reason of any option, warrant, scrip,
preemptive right, right to subscribe to, gross-up right, call or
commitment of any character whatsoever relating to, or security or
right convertible into, shares of any capital stock of such Company
Subsidiary, and there are no contracts, commitments, understandings
or arrangements by which any Company Subsidiary is bound to issue
additional shares of its capital stock, or any option, warrant or
right to purchase or acquire any additional shares of its
capital
-9-
stock. All of such shares so owned by the
Company are duly authorized and validly issued, fully paid and
nonassessable and are owned by it free and clear of any lien,
adverse right or claim, charge, option, pledge, covenant, title
defect, security interest or other encumbrances of any kind
(“ Liens ”) with respect thereto. Each Company
Subsidiary is an entity duly organized, validly existing, duly
qualified to do business and in good standing under the laws of its
jurisdiction of incorporation, and has corporate or other
appropriate organizational power and authority to own or lease its
properties and assets and to carry on its business as it is now
being conducted, in each case except as would not reasonably be
expected to have a Material Adverse Effect on the Company. Except
in respect of the Company Subsidiaries, the Company does not own
beneficially, directly or indirectly, more than 5% of any class of
equity securities or similar interests of any corporation, bank,
business trust, association or similar organization, and is not,
directly or indirectly, a partner in any partnership or party to
any joint venture. The Company’s principal depository
institution subsidiary is duly organized and validly existing as a
national banking association and its deposit accounts are insured
by the Federal Deposit Insurance Corporation (“ FDIC
”) to the fullest extent permitted by the Federal Deposit
Insurance Act and the rules and regulations of the FDIC thereunder,
and all premiums and assessments required to be paid in connection
therewith have been paid when due.
(c) Capitalization . The
authorized capital stock of the Company consists of 200,000,000
shares of Common Stock and 3,000,000 shares of preferred stock, par
value $0.01 per share (the “ Company Preferred Stock
”). As of the close of business on July 24, 2009 (the
“ Capitalization Date ”), there were 64,098,478
shares of Common Stock outstanding and 456,400 shares of Company
Preferred Stock outstanding, consisting of 56,400 shares
designated as 8.50% Series A Non-Cumulative Perpetual Convertible
Preferred Stock (the “ Series A Stock ”) and
400,000 shares designated as Fixed Rate Cumulative Perpetual
Preferred Stock, Series B (the “ Series B Stock
”). Since the Capitalization Date and through the date of
this Agreement, except in connection with the Transaction Documents
and the transactions contemplated hereby and thereby, the Company
has not (i) issued or authorized the issuance of any shares of
Common Stock or Company Preferred Stock, or any securities
convertible into or exchangeable or exercisable for shares of
Common Stock or Company Preferred Stock, (ii) reserved for
issuance any shares of Common Stock or Company Preferred Stock or
(iii) repurchased or redeemed, or authorized the repurchase or
redemption of, any shares of Common Stock or Company Preferred
Stock. As of the close of business on the Capitalization Date,
other than in respect of the Series A Stock, the warrant for Common
Stock issued in connection with the issuance of the Series B Stock
and awards outstanding under or pursuant to the Benefit Plans and
the Company’s Dividend Reinvestment and Stock Purchase Plan
in respect of which an aggregate of 18,198,083 shares of Common
Stock have been reserved for issuance, no shares of Common Stock or
Company Preferred Stock were reserved for issuance. All of the
issued and outstanding shares of Common Stock and Company Preferred
Stock have been duly authorized and validly issued and are fully
paid, nonassessable and free of preemptive rights, with no personal
liability attaching to the ownership thereof. No bonds, debentures,
notes or other indebtedness
-10-
having the right to vote on any matters on which
the stockholders of the Company may vote (“ Voting
Debt ”) are issued and outstanding. As of the date of
this Agreement, except (i) pursuant to any cashless exercise
provisions of any Company stock options or pursuant to the
surrender of shares to the Company or the withholding of shares by
the Company to cover tax withholding obligations under the Benefit
Plans, and (ii) as set forth elsewhere in this
Section 2.2(c), the Company does not have and is not bound by
any outstanding subscriptions, options, warrants, calls,
commitments or agreements of any character calling for the purchase
or issuance of, or securities or rights convertible into or
exchangeable or exercisable for, any shares of Common Stock or
Company Preferred Stock or any other equity securities of the
Company or Voting Debt or any securities representing the right to
purchase or otherwise receive any shares of capital stock of the
Company (including any rights plan or agreement). The Company has
Previously Disclosed all shares of Company capital stock that have
been purchased, redeemed or otherwise acquired, directly or
indirectly, by the Company or any Company Subsidiary since
December 31, 2008 and all dividends or other distributions
that have been declared, set aside, made or paid to the
stockholders of the Company since that date.
(d) Authorization
.
(1) The Company has the corporate
power and authority to enter into or issue this Agreement and the
Warrants and to carry out its obligations hereunder and thereunder.
The execution, delivery and performance of this Agreement and the
Warrants by the Company and the consummation of the transactions
contemplated hereby and thereby, including the issuance of Common
Stock in accordance with the Preferred Shares and the Warrants,
have been duly authorized by the affirmative vote of at least
two-thirds of the directors on the Board of Directors of the
Company (the “ Board of Directors ”). This
Agreement and the Warrants have been duly and validly executed and
delivered by the Company and, assuming due authorization, execution
and delivery of this Agreement by the Investor, are valid and
binding obligations of the Company enforceable against the Company
in accordance with their respective terms, except as such
enforceability may be limited by bankruptcy, insolvency,
moratorium, reorganizations, fraudulent transfer or similar laws
relating to or affecting creditors generally or by general
equitable principles (whether applied in equity or at law). No
other corporate proceedings are necessary for the execution and
delivery by the Company of this Agreement and the Warrants, the
performance by it of its obligations hereunder and thereunder or
the consummation by it of the transactions contemplated hereby and
thereby, subject to receipt of the approval by the Company’s
stockholders of the Stockholder Proposals. The only vote of the
stockholders of the Company required to approve (i) the
conversion of the Preferred Stock into, and exercise of the
Warrants for, Common Stock for purposes of Section 312.03 of
the NYSE Listed Company Manual, is a majority of the votes cast on
such proposal, provided that the total vote cast on the
proposal represents over 50% in interest of all securities entitled
to vote on the proposal and (ii) the exemption of the Investor
and its Affiliates
-11-
from all stock ownership
restrictions under the Certificate of Incorporation, is the
affirmative vote of the holders of at least two-thirds of the
shares of “voting stock,” as defined in Article 10
of the Certificate of Incorporation. Assuming that immediately
prior to the consummation of the sale of Common Stock to the
Investor as set forth herein, Investor’s representation in
Section 2.3(d) is true and correct and that as of the date of
this Agreement, none of the Investor’s Affiliates are the
owners of record or the Beneficial Owners of shares of Common
Stock, securities convertible into or exchangeable for Common Stock
or any other equity or equity-linked security of the Company or any
of its Subsidiaries, none of the shares of Common Stock issued and
sold to the Investor hereunder (for the avoidance of doubt,
including Common Stock issuable upon exercise of the Warrants or
conversion of the Preferred Shares, subject to receipt of the
approval by the Company’s stockholders of the Stockholder
Proposals) will be subject to the provisions of Subsection 3
of Article 10 of the Certificate of Incorporation.
(2) Neither the execution, delivery
and performance by the Company of this Agreement and the Warrants,
nor the consummation of the transactions contemplated hereby and
thereby, nor compliance by the Company with any of the provisions
thereof, will (i) violate, conflict with, or result in a
breach of any provision of, or constitute a default (or an event
which, with notice or lapse of time or both, would constitute a
default) under, or result in the termination of, or accelerate the
performance required by, or result in a right of termination or
acceleration of, or result in the creation of, any Lien, upon any
of the properties or assets of the Company or any Company
Subsidiary under any of the material terms, conditions or
provisions of (A) its certificate of incorporation or bylaws
(or similar governing documents) or (B) any note, bond,
mortgage, indenture, deed of trust, license, lease, agreement or
other instrument or obligation to which the Company or any Company
Subsidiary is a party or by which it may be bound, or to which the
Company or any Company Subsidiary or any of the properties or
assets of the Company or any Company Subsidiary may be subject, or
(ii) subject to compliance with the statutes and regulations
referred to in the next paragraph, violate any ordinance, permit,
concession, grant, franchise, law, statute, rule or regulation or
any judgment, ruling, order, writ, injunction or decree applicable
to the Company or any Company Subsidiary or any of their respective
properties or assets except in the case of clauses (i)(B) and
(ii) for such violations, conflicts and breaches as would not
reasonably be expected to have a Material Adverse Effect on the
Company.
(3) Other than (i) the
securities or blue sky laws of the various states, no material
notice to, registration, declaration or filing with and
(ii) in connection with the Second Closing only, the Hart
Scott Rodino Antitrust Improvements Act of 1976 (the “ HSR
Act ”) or competition or merger control laws of other
jurisdictions, exemption or review by, or authorization, order,
consent or approval of, any Governmental Entity, or expiration or
termination of any statutory waiting period, is necessary for the
consummation by the Company of the transactions contemplated by
this Agreement.
-12-
(e) Knowledge as to
Conditions . As of the date of this Agreement, the Company
knows of no reason why any regulatory approvals and, to the extent
necessary, any other approvals, authorizations, filings,
registrations, and notices required or otherwise a condition to the
consummation of the transactions contemplated by the Transaction
Documents cannot, or should not, be obtained.
(f) Financial Statements .
The consolidated balance sheets of the Company and the Company
Subsidiaries as of December 31, 2008 and 2007 and related
consolidated statements of income, stockholders’ equity and
cash flows for the three years ended December 31, 2008,
together with the notes thereto, certified by KPMG LLP and included
in the Company’s Annual Report on Form 10-K for the fiscal
year ended December 31, 2008 (the “ Company 10-K
”), as filed with the U.S. Securities and Exchange Commission
(the “ SEC ”), and the unaudited consolidated
balance sheets of the Company and the Company Subsidiaries as of
March 31, 2009 and related consolidated statements of income,
stockholders’ equity and cash flows for the quarter then
ended, included in the Company’s Quarterly Report on Form
10-Q for the period ended March 31, 2009, and the unaudited
selected financial highlights, including the consolidated balance
sheets and related consolidated statement of income for the quarter
ended June 30, 2009, included in the Current 8-K Report filed
by the Company on July 17, 2009 (collectively, the “
Company Financial Statements ”), (1) have been
prepared from, and are in accordance with, the books and records of
the Company and the Company Subsidiaries, (2) complied as to
form, as of their respective date of filing with the SEC, in all
material respects with applicable accounting requirements and with
the published rules and regulations of the SEC with respect
thereto, (3) have been prepared in accordance with GAAP
applied on a consistent basis and (4) present fairly in all
material respects the consolidated financial position of the
Company and the Company Subsidiaries at the dates set forth therein
and the consolidated results of operations, changes in
stockholders’ equity and cash flows of the Company and the
Company Subsidiaries for the periods stated therein (subject to the
absence of notes and year-end audit adjustments in the case of
interim unaudited statements).
(g) Reports .
(1) Since December 31, 2006,
the Company and each Company Subsidiary have filed all material
reports, registrations, documents, filings, statements and
submissions together with any required amendments thereto, that it
was required to file with any Governmental Entity (the foregoing,
collectively, the “ Company Reports ”) and have
paid all material fees and assessments due and payable in
connection therewith. As of their respective filing dates, the
Company Reports complied in all material respects with all statutes
and applicable rules and regulations of the applicable Governmental
Entities, as the case may be. To the knowledge of the Company, as
of the date of this Agreement, there are no
-13-
outstanding comments from the SEC or
any other Governmental Entity with respect to any Company Report.
The Company Reports, including the documents incorporated by
reference in each of them, each contained all of the information
required to be included in it and, when it was filed and as of the
date of each such Company Report filed with or furnished to the
SEC, such Company Report did not, as of its date or if amended
prior to the date of this Agreement, as of the date of such
amendment, contain an untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements
made in it, in light of the circumstances under which they were
made, not misleading and complied as to form in all material
respects with the applicable requirements of the Securities Act of
1933, as amended, or any successor statute (the “
Securities Act ”), and the Securities Exchange Act of
1934, as amended, or any successor statute (the “ Exchange
Act ”). No executive officer of the Company has failed in
any respect to make the certifications required of him or her under
Section 302 or 906 of the Sarbanes-Oxley Act of 2002. To the
knowledge of the Company as of the date hereof, there are no facts
or circumstances that would prevent its chief executive officer and
chief financial officer from giving the certifications and
attestations required pursuant to Rules 13a-14 and 15d-14 under the
Exchange Act, without qualification, with respect to the Quarterly
Report on Form 10-Q for the fiscal quarter ended June 30,
2009.
(2) The records, systems, controls,
data and information of the Company and the Company Subsidiaries
are recorded, stored, maintained and operated under means
(including any electronic, mechanical or photographic process,
whether computerized or not) that are under the exclusive ownership
and direct control of the Company or the Company Subsidiaries or
accountants (including all means of access thereto and therefrom),
except for any nonexclusive ownership and nondirect control that
would not, individually or in the aggregate, reasonably be expected
to have a material adverse effect on the system of internal
accounting controls described below in this Section 2.2(g).
The Company (A) has implemented and maintains disclosure
controls and procedures (as defined in Rule 13a-15(e) of the
Exchange Act) to ensure that material information relating to the
Company, including its consolidated subsidiaries, is made known to
the chief executive officer and the chief financial officer of the
Company by others within those entities, and (B) has
disclosed, based on its most recent evaluation prior to the date of
this Agreement, to the Company’s outside auditors and the
audit committee of the Board of Directors (x) any significant
deficiencies and material weaknesses in the design or operation of
internal control over financial reporting (as defined in Rule
13a-15(f) of the Exchange Act) that are reasonably likely to
adversely affect the Company’s ability to record, process,
summarize and report financial information, and (y) any fraud,
whether or not material, that involves management or other
employees who have a significant role in the Company’s
internal controls over financial reporting. As of the date of this
Agreement, the Company has no knowledge of any reason that its
outside auditors and its chief executive officer and chief
financial officer will not be able
-14-
to give the certifications and
attestations required pursuant to the rules and regulations adopted
pursuant to Section 404 of the Sarbanes-Oxley Act of 2002,
without qualification, when next due. Since December 31, 2006,
(i) neither the Company nor any Company Subsidiary nor, to the
knowledge of the Company, any director, officer, employee, auditor,
accountant or representative of the Company or any Company
Subsidiary has received or otherwise had or obtained knowledge of
any material complaint, allegation, assertion or claim, whether
written or oral, regarding the accounting or auditing practices,
procedures, methodologies or methods of the Company or any Company
Subsidiary or their respective internal accounting controls,
including any material complaint, allegation, assertion or claim
that the Company or any Company Subsidiary has engaged in
questionable accounting or auditing practices, and (ii) no
attorney representing the Company or any Company Subsidiary,
whether or not employed by the Company or any Company Subsidiary,
has reported evidence of a material violation of securities laws,
breach of fiduciary duty or similar violation by the Company or any
of its officers, directors, employees or agents to the Board of
Directors or any committee thereof or to any director or officer of
the Company.
(h) Properties and Leases .
To the extent reflected in the Company Financial Statements, except
for any Permitted Liens, the Company and each Company Subsidiary
have good title free and clear of any material Liens to all the
real and personal property reflected in the Company’s
consolidated balance sheet as of December 31, 2008 included in
the Company 10-K for the period then ended, and all real and
personal property acquired since such date, except such real and
personal property as has been disposed of in the ordinary course of
business. For purposes of this Agreement, “ Permitted
Liens ” means (i) liens for taxes and other
governmental charges and assessments which are not yet due and
payable, (ii) liens of landlords and liens of carriers,
warehousemen, mechanics and materialmen and other like liens
arising in the ordinary course of business for sums not yet due and
payable, and (iii) other Liens or imperfections on property
which are not material in amount or do not materially detract from
the value of or materially impair the existing use of the property
affected by such Lien or imperfection. Except as would not
reasonably be expected to have a Material Adverse Effect on the
Company, (i) all leases of real property and all other leases
material to the Company or any Company Subsidiary pursuant to which
the Company or such Company Subsidiary, as lessee, leases real or
personal property are valid and effective in accordance with their
respective terms, and (ii) there is not, under any such lease,
any existing default by the Company or such Company Subsidiary or
any event which, with notice or lapse of time or both, would
constitute such a default.
(i) Taxes . Except as would
not, individually or in the aggregate, be reasonably likely to have
a Material Adverse Effect on the Company, each of the Company and
the Company Subsidiaries has filed all federal, state, county,
local and foreign Tax returns, including information returns,
required to be filed by it and all such filed Tax returns are,
true, complete and correct in all respects, and paid all Taxes owed
by it and no Taxes owed by it or assessments received by it are
delinquent. The federal
-15-
income Tax returns of the Company and the
Company Subsidiaries for the fiscal year ended December 31,
2008, and for all fiscal years prior thereto, are for the purposes
of routine audit by the Internal Revenue Service (the “
IRS ”) closed because of the statute of limitations,
and no claims for additional Taxes for such fiscal years are
pending. Neither the Company nor any Company Subsidiary has waived
any statute of limitations with respect to Taxes or agreed to any
extension of time with respect to a Tax assessment or deficiency,
in each case that is still in effect, or has pending a request for
any such extension or waiver. Neither the Company nor any Company
Subsidiary is a party to any pending action or proceeding, nor to
the Company’s knowledge is any such action or proceeding
threatened by any Governmental Entity, for the assessment or
collection of Taxes, interest, penalties, assessments or
deficiencies that could reasonably be likely to have a Material
Adverse Effect on the Company and no issue has been raised by any
federal, state, local or foreign taxing authority in connection
with an audit or examination of the Tax returns, business or
properties of the Company or any Company Subsidiary which has not
been settled, resolved and fully satisfied, or adequately reserved
for (other than those issues that would not be reasonably likely to
have a Material Adverse Effect on the Company). Except as would not
be reasonably likely to have a Material Adverse Effect on the
Company, each of the Company and the Company Subsidiaries has
withheld and paid all Taxes that it is required to withhold from
amounts owing to employees, creditors or other third parties.
Neither the Company nor any Company Subsidiary is a party to, is
bound by or has any obligation under any material Tax sharing or
material Tax indemnity agreement or similar contract or arrangement
other than any contract or agreement between or among the Company
and any Company Subsidiary. Neither the Company nor any Company
Subsidiary has entered into any “listed transaction”
within the meaning of Treasury Regulations
Section 1.6011-4(b)(2), or any other transaction requiring
disclosure under analogous provisions of state, local or foreign
law. Neither the Company nor any Company Subsidiary has liability
for the Taxes of any person other than the Company or any Company
Subsidiary under Treasury Regulations Section 1.1502-6 (or any
similar provision of state, local or foreign law). For the purpose
of this Agreement, the term “ Tax ” (including,
with correlative meaning, the term “ Taxes ”)
shall mean any and all domestic or foreign, federal, state, local
or other taxes of any kind (together with any and all interest,
penalties, additions to tax and additional amounts imposed with
respect thereto) imposed by any Governmental Entity, including
taxes on or with respect to income, franchises, windfall or other
profits, gross receipts, property, sales, use, capital stock,
payroll, employment, unemployment, social security, workers’
compensation or net worth, and taxes in the nature of excise,
withholding, ad valorem or value added.
(j) Absence of Certain
Changes . Since December 31, 2008, except for publicly
disclosed ordinary dividends on the Common Stock and outstanding
Company Preferred Stock, the Company has not made or declared any
distribution in cash or in kind to its stockholders or issued or
repurchased any shares of its capital stock or other equity
interests. Since December 31, 2008 to and including the date
hereof, no event or events have occurred that have had or is
reasonably likely to have had a Material Adverse Effect on the
Company.
-16-
(k) Commitments and Contracts
. The Company has Previously Disclosed or provided to the Investor
or its representatives true, correct and complete copies of each of
the following to which the Company or any Company Subsidiary is a
party or subject (whether written or oral, express or implied)
(each, a “ Company Significant Agreement
”):
(1) any material employment contract
or understanding (including any understandings or obligations with
respect to severance or termination pay, liabilities or fringe
benefits) with any present or former officer, director, employee or
consultant (other than those that are terminable at will by the
Company or such Company Subsidiary);
(2) any material plan, contract or
understanding providing for any bonus, pension, option, deferred
compensation, retirement payment, profit sharing or similar
arrangement with respect to any present or former officer,
director, employee or consultant;
(3) any material labor contract or
agreement with any labor union;
(4) any contract containing
covenants that limit in any material respect the ability of the
Company or any Company Subsidiary to compete in any line of
business or with any person or which involve any material
restriction of the geographical area in which, or method by which
or with whom, the Company or any Company Subsidiary may carry on
its business (other than as may be required by law or applicable
regulatory authorities);
(5) any joint venture, partnership,
strategic alliance or other similar contract (including any
franchising agreement, but in any event excluding introducing
broker agreements); and any contract relating to the acquisition or
disposition of any material business or material assets (whether by
merger, sale of stock or assets or otherwise), which acquisition or
disposition is not yet complete or where such contract contains
continuing material obligations or contains continuing indemnity
obligations of the Company or any of the Company
Subsidiaries;
(6) any real property lease and any
other lease with annual rental payments aggregating $5,000,000 or
more; and
(7) any other contract or agreement
which is a “material contract” within the meaning of
Item 601(b)(10) of
Regulation S-K.
Each of the Company Significant
Agreements is valid and binding on the Company and the Company
Subsidiaries, as applicable, and in full force and effect. The
Company and each of the Company Subsidiaries, as applicable, are in
all material respects in compliance with and have in all material
respects performed all obligations required to be performed by them
to date under each Company Significant Agreement. Neither
the
-17-
Company nor any of the Company Subsidiaries
knows of, or has received notice of, any material violation or
default (or any condition which with the passage of time or the
giving of notice would cause such a violation of or a default) by
any party under any Company Significant Agreement. To the
Company’s knowledge, as of the date of this Agreement, there
are no material transactions or series of related transactions,
agreements, arrangements or understandings, nor are there any
currently proposed material transactions, or series of related
transactions between the Company or any Company Subsidiaries, on
the one hand, and the Company, any current or former director or
executive officer of the Company or any Company Subsidiaries or any
person who Beneficially Owns 5% or more of the Common Shares (or
any of such person’s immediate family members or Affiliates)
(other than Company Subsidiaries), on the other hand.
(l) Offering of Securities .
Neither the Company nor any person acting on its behalf has taken
any action (including, any offering of any securities of the
Company under circumstances which would require the integration of
such offering with the offering of any of the Securities to be
issued pursuant to this Agreement or any other Transaction Document
under the Securities Act and the rules and regulations of the SEC
promulgated thereunder) which would subject the offering, issuance
or sale of any of such Securities to the registration requirements
of the Securities Act.
(m) Litigation and Other
Proceedings; No Undisclosed Liabilities .
(1) There is no pending or, to the
knowledge of the Company, threatened, claim, action, suit,
investigation or proceeding, against the Company or any Company
Subsidiary, nor is the Company or any Company Subsidiary subject to
any order, judgment or decree, in each case except as would not
reasonably be expected to have a Material Adverse Effect on the
Company.
(2) Neither the Company nor any of
the Company Subsidiaries has any liabilities or obligations of any
nature (absolute, accrued, contingent or otherwise) which are not
appropriately reflected or reserved against in the financial
statements described in Section 2.2(f) to the extent required
to be so reflected or reserved against in accordance with GAAP,
except for (i) liabilities that have arisen since
March 31, 2009 in the ordinary course of business consistent
with past practice and (ii) liabilities that have not had and
would not reasonably be expected to have a Material Adverse
Effect.
(n) Compliance with Laws and
Other Matters; Insurance . The Company and each Company
Subsidiary:
(1) in the conduct of its business
is in material compliance with all, and the condition and use of
its properties does not violate or infringe in any material respect
any, applicable material domestic (federal, state or local) or
foreign laws, statutes, ordinances, licenses, rules, regulations
judgments, demands, writs, injunctions, orders or decrees
applicable thereto or to employees conducting
-18-
its business, including the Troubled
Asset Relief Program, the Sarbanes-Oxley Act of 2002, the Equal
Credit Opportunity Act, the Fair Housing Act, the Community
Reinvestment Act, the Home Mortgage Disclosure Act, the Uniting and
Strengthening America by Providing Appropriate Tools Required to
Intercept and Obstruct Terrorism (USA PATRIOT) Act of 2001, all
other applicable fair lending laws or other laws relating to
discrimination and the Bank Secrecy Act, and, as of the date
hereof, the Company’s principal depository institution
subsidiary that is an insured depository institution has a
Community Reinvestment Act rating of “satisfactory” or
better and is “well managed” and “well
capitalized,” as defined in Regulation Y of the Federal
Reserve;
(2) has all material permits,
licenses, franchises, authorizations, orders and approvals of, and
has made all filings, applications and registrations with,
Governmental Entities that are required in order to permit it to
own or lease its properties and assets and to carry on its business
as presently conducted and that are material to the business of the
Company or such Company Subsidiary; and all such material permits,
licenses, certificates of authority, orders and approvals are in
full force and effect and, to the knowledge of the Company, no
material suspension or cancellation of any of them is threatened,
and all such filings, applications and registrations are
current;
(3) currently is complying with and
is not under investigation with respect to or, to the knowledge of
the Company, has been threatened to be charged with or given notice
of any material violation of, all applicable federal, state, local
and foreign laws, regulations, rules, judgments, injunctions or
decrees;
(4) has, except for statutory or
regulatory restrictions of general application, not been placed
under any material restriction by a Governmental Entity on its
business or properties, and except for routine examinations by
applicable Governmental Entities, as of the date of this Agreement,
received no notification or communication from any Governmental
Entity that an investigation by any Governmental Entity with
respect to the Company or any of the Company Subsidiaries is
pending or threatened;
(5) has not, since January 1,
2006 nor to its knowledge, has any other person on behalf of the
Company or any Company Subsidiary that qualifies as a
“financial institution” under the U.S. Anti-Money
Laundering laws, knowingly acted, by itself or in conjunction with
another, in any act in connection with the concealment of any
currency, securities or other proprietary interest that is the
result of a felony as defined in the U.S. Anti-Money Laundering
laws (“ Unlawful Gains ”), nor knowingly
accepted, transported, stored, dealt in or brokered any sale,
purchase or any transaction of other nature for Unlawful
Gains;
-19-
(6) to the extent it qualifies as a
“financial institution” under the U.S. Anti-Money
Laundering laws, has implemented in all material respects such anti
money laundering mechanisms and kept and filed all material reports
and other necessary material documents as required by, and
otherwise complied in all material respects with, the U.S.
Anti-Money Laundering laws and the rules and regulations
thereunder; and
(7) is presently insured, and during
each of the past two calendar years (or during such lesser period
of time as the Company has owned such Company Subsidiary) has been
insured, for reasonable amounts with financially sound and
reputable insurance companies against such risks as companies
engaged in a similar business would, in accordance with industry
practice, customarily be insured.
(o) Labor . Employees of the
Company and the Company Subsidiaries are not represented by any
labor union nor are any collective bargaining agreements otherwise
in effect with respect to such employees. No labor organization or
group of employees of the Company or any Company Subsidiary has
made a pending demand for recognition or certification, and there
are no representation or certification proceedings or petitions
seeking a representation proceeding presently pending or, to the
Company’s knowledge, threatened to be brought or filed with
the National Labor Relations Board or any other labor relations
tribunal or authority. There are no organizing activities, strikes,
work stoppages, slowdowns, lockouts, material arbitrations or
material grievances, or other material labor disputes pending or,
to the Company’s knowledge, threatened against or involving
the Company or any Company Subsidiary.
(p) Company Benefit Plans
.
(1) “ Benefit Plan
” means all material employee benefit plans, programs,
agreements, policies, practices, or other arrangements providing
benefits to any current or former employee, officer or director of
the Company or any Company Subsidiary or any beneficiary or
dependent thereof that is sponsored or maintained by the Company or
any Company Subsidiary or to which the Company or any Company
Subsidiary contributes or is obligated to contribute or is party,
whether or not written, including any material employee welfare
benefit plan within the meaning of Section 3(1) of the
Employee Retirement Income Security Act of 1974, as amended
(“ ERISA ”), any employee pension benefit plan
within the meaning of Section 3(2) of ERISA (whether or not
such plan is subject to ERISA) and any material bonus, incentive,
deferred compensation, vacation, stock purchase, stock option,
equity-based severance, employment, change of control, consulting
or fringe benefit plan, program, agreement or policy.
(2) With respect to each Benefit
Plan, (A) the Company and the Company Subsidiaries have
complied, and are now in compliance, in all material respects, with
the applicable provisions of ERISA, the Code and all other laws and
regulations applicable to such Benefit Plan and (B) each
Benefit Plan has
-20-
been administered in all material
respects in accordance with its terms. Except as would not
reasonably be expected to have a Material Adverse Effect on the
Company, none of the Company and the Company Subsidiaries nor any
of their respective ERISA Affiliates has incurred any withdrawal
liability as a result of a complete or partial withdrawal from a
multiemployer plan, as those terms are defined in Part I of
Subtitle E of Title IV of ERISA, that has not been satisfied in
full. “ ERISA Affiliate ” means any entity,
trade or business, whether or not incorporated, which together with
the Company and the Company Subsidiaries would be deemed a
“single employer” within the meaning of
Section 4001 of ERISA or Sections 414(b), (c), (m) or
(o) of the Code.
(3) Neither the execution and
delivery of this Agreement, nor the consummation of the
transactions contemplated hereby will (i) result in any
material payment (including severance, unemployment compensation,
“excess parachute payment” (within the meaning of
Section 280G of the Code), forgiveness of indebtedness or
otherwise) becoming due to any current or former employee, officer
or director of the Company or any Company Subsidiary from the
Company or any Company Subsidiary under any Benefit Plan or any
other agreement with any employee, including, for the avoidance of
doubt, change in control agreements, (ii) materially increase
any benefits otherwise payable under any Benefit Plan,
(iii) result in any acceleration of the time of payment or
vesting of any such benefits, (iv) require the funding or
increase in the funding of any such benefits or (v) result in
any limitation on the right of the Company or any Company
Subsidiary to amend, merge, terminate or receive a reversion of
assets from any Benefit Plan or related trust.
(4) Except as would not reasonably
be expected to have a Material Adverse Effect on the Company and
except for liabilities fully reserved for or identified in the
Company Financial Statements, there are no pending or threatened
claims (other than claims for benefits in the ordinary course),
lawsuits or arbitrations which have been asserted or instituted
against (i) the Benefit Plans, (ii) any fiduciaries
thereof with respect to their duties to the Benefit Plans, or
(iii) the assets of any of the trusts under any of the Benefit
Plans.
(q) Status of Securities .
The shares of Common Stock and shares of Preferred Stock (upon
filing of the applicable Preferred Stock Certificates of
Designations with the Delaware Secretary) and the Warrants to be
issued pursuant to this Agreement have been duly authorized by all
necessary corporate action of the Company. When issued and sold
against receipt of the consideration therefore as provided in this
Agreement, such shares of Common Stock and Preferred Stock will be
validly issued, fully paid and nonassessable, will not subject the
holders thereof to personal liability and will not be subject to
preemptive rights of any other stockholder of the Company. The
shares of Common Stock issuable upon the conversion of the
Preferred Stock and exercise of the Warrants will, upon receipt of
the approval by the Company’s stockholders of the Stockholder
Proposals and filing of the applicable Preferred Stock
-21-
Certificate of Designations with the Delaware
Secretary, have been duly authorized by all necessary corporate
action and, when so issued, upon such conversion or exercise will
be validly issued, fully paid and nonassessable, will not subject
the holders thereof to personal liability and will not be subject
to preemptive rights of any other stockholder of the Company. Each
of the Warrants, when executed and delivered by the Company
pursuant to this Agreement, will constitute a valid and legally
binding agreement of the Company enforceable in accordance with its
terms (except as enforcement may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, fraudulent
transfer and similar laws relating to or affecting creditors
generally or by general equitable principles (whether applied in
equity or at law)).
(r) Investment Company;
Investment Adviser . Neither the Company nor any of the Company
Subsidiaries is an “investment company” as defined
under the Investment Company Act of 1940, as amended, and neither
the Company nor any of the Company Subsidiaries sponsors any person
that is such an investment company. The Company’s investment
adviser subsidiary which is required to be registered as an
“investment advisor” under the Investment Advisers Act
of 1940, as amended, or in another capacity with the SEC or any
other Governmental Entity is duly registered as such and such
registrations are in full force and effect.
(s) Risk Management;
Derivatives . Except as would not reasonably be expected to
have a Material Adverse Effect on the Company:
(1) The Company and the Company
Subsidiaries have in place risk management policies and procedures
sufficient in scope and operation to protect against risks of the
type and in amounts reasonably expected to be incurred by persons
of similar size and in similar lines of business as the Company and
the Company Subsidiaries.
(2) All derivative instruments,
including swaps, caps, floors and option agreements, whether
entered into for the Company’s own account, or for the
account of one or more of the Company Subsidiaries or their
customers, were entered into (i) only for purposes of
mitigating identified risk and in the ordinary course of business,
(ii) in accordance with prudent practices and in all material
respects with all applicable laws, rules, regulations and
regulatory policies, and (iii) with counterparties believed by
the Company to be financially responsible at the time; and each of
them constitutes the valid and legally binding obligation of the
Company or one of the Company Subsidiaries, enforceable in
accordance with its terms. Neither the Company nor the Company
Subsidiaries, nor any other party thereto, is in breach of any of
its obligations under any such agreement or arrangement.
(t) Foreign Corrupt Practices and
International Trade Sanctions . Neither the Company nor any
Company Subsidiary, nor any of their respective directors,
officers, agents, employees or any other persons acting on their
behalf (i) has violated the
-22-
Foreign Corrupt Practices Act, 15 U.S.C. §
78dd-1 et seq., as amended, or any other similar applicable
foreign, federal, or state legal requirement, (ii) has made or
provided, or caused to be made or provided, directly or indirectly,
any payment or thing of value to a foreign official, foreign
political party, candidate for office or any other person knowing
that the person will pay or offer to pay the foreign official,
party or candidate, for the purpose of influencing a decision,
inducing an official to violate their lawful duty, securing any
improper advantage, or inducing a foreign official to use their
influence to affect a governmental decision, (iii) has paid,
accepted or received any unlawful contributions, payments,
expenditures or gifts, (iv) has violated or operated in
noncompliance with any export restrictions, money laundering law,
anti-terrorism law or regulation, anti-boycott regulations or
embargo regulations, or (v) is currently subject to any United
States sanctions administered by the Office of Foreign Assets
Control of the United States Treasury Department.
(u) Environmental Liability .
There is no legal, administrative, or other proceeding, claim or
action of any nature seeking to impose, or that could result in the
imposition of, on the Company or any Company Subsidiary, any
liability relating to the release of hazardous substances as
defined under any local, state or federal environmental statute,
regulation or ordin